Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Megakaryocytic Progenitor Cells for Thrombocytopenia in Acute Leukemia
NCT02241031Phase 3Unknown
- Sponsor
- Nanfang Hospital, Southern Medical University
- Start
- Sep 2014
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in Thrombocytopenia (2 arms), sponsored by Nanfang Hospital, Southern Medical University. Primary endpoint: Platelet recovery after infusion of MPs at 3 months. Status: unknown.
02
Conditions
Thrombocytopenia
Beyond the preview
Go deeper on NCT02241031.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02241031.